210 related articles for article (PubMed ID: 16825485)
1. Molecular determinants of pyrantel selectivity in nicotinic receptors.
Bartos M; Rayes D; Bouzat C
Mol Pharmacol; 2006 Oct; 70(4):1307-18. PubMed ID: 16825485
[TBL] [Abstract][Full Text] [Related]
2. Activation of single nicotinic receptor channels from Caenorhabditis elegans muscle.
Rayes D; Flamini M; Hernando G; Bouzat C
Mol Pharmacol; 2007 May; 71(5):1407-15. PubMed ID: 17314321
[TBL] [Abstract][Full Text] [Related]
3. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
[TBL] [Abstract][Full Text] [Related]
4. Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in Ascaris.
Martin RJ; Clark CL; Trailovic SM; Robertson AP
Int J Parasitol; 2004 Aug; 34(9):1083-90. PubMed ID: 15313135
[TBL] [Abstract][Full Text] [Related]
5. Glutamine 57 at the complementary binding site face is a key determinant of morantel selectivity for {alpha}7 nicotinic receptors.
Bartos M; Price KL; Lummis SC; Bouzat C
J Biol Chem; 2009 Aug; 284(32):21478-87. PubMed ID: 19506073
[TBL] [Abstract][Full Text] [Related]
6. Determinants of channel gating located in the N-terminal extracellular domain of nicotinic alpha7 receptor.
Anand R; Nelson ME; Gerzanich V; Wells GB; Lindstrom J
J Pharmacol Exp Ther; 1998 Nov; 287(2):469-79. PubMed ID: 9808669
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine receptor subunit genes from Ancylostoma caninum: altered transcription patterns associated with pyrantel resistance.
Kopp SR; Coleman GT; Traub RJ; McCarthy JS; Kotze AC
Int J Parasitol; 2009 Mar; 39(4):435-41. PubMed ID: 18823982
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the differential sensitivity of nematode and mammalian muscle to the anthelmintic agent levamisole.
Rayes D; De Rosa MJ; Bartos M; Bouzat C
J Biol Chem; 2004 Aug; 279(35):36372-81. PubMed ID: 15201284
[TBL] [Abstract][Full Text] [Related]
9. Contribution of subunits to Caenorhabditis elegans levamisole-sensitive nicotinic receptor function.
Hernando G; Bergé I; Rayes D; Bouzat C
Mol Pharmacol; 2012 Sep; 82(3):550-60. PubMed ID: 22734069
[TBL] [Abstract][Full Text] [Related]
10. Comparative neuromuscular blocking actions of levamisole and pyrantel-type anthelmintics on rat and gastrointestinal nematode somatic muscle.
Atchison WD; Geary TG; Manning B; VandeWaa EA; Thompson DP
Toxicol Appl Pharmacol; 1992 Jan; 112(1):133-43. PubMed ID: 1310165
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic contributions of residues in the M1 transmembrane domain of the nicotinic receptor to channel gating.
Spitzmaul G; Corradi J; Bouzat C
Mol Membr Biol; 2004; 21(1):39-50. PubMed ID: 14668137
[TBL] [Abstract][Full Text] [Related]
12. Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57.
Martin RJ; Robertson AP
Parasitology; 2007; 134(Pt 8):1093-104. PubMed ID: 17608969
[TBL] [Abstract][Full Text] [Related]
13. Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans.
Ruiz-Lancheros E; Viau C; Walter TN; Francis A; Geary TG
Int J Parasitol; 2011 Mar; 41(3-4):455-61. PubMed ID: 21195075
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of a mutated chicken alpha7 nicotinic acetylcholine receptor subunit with a leucine residue inserted in transmembrane domain 2.
Buckingham SD; Adcock C; Sansom MS; Sattelle DB; Baylis HA
Br J Pharmacol; 1998 Jun; 124(4):747-55. PubMed ID: 9690867
[TBL] [Abstract][Full Text] [Related]
15. Activation of
Turani O; Hernando G; Corradi J; Bouzat C
Mol Pharmacol; 2018 Nov; 94(5):1270-1279. PubMed ID: 30190363
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species.
Blanchard A; Guégnard F; Charvet CL; Crisford A; Courtot E; Sauvé C; Harmache A; Duguet T; O'Connor V; Castagnone-Sereno P; Reaves B; Wolstenholme AJ; Beech RN; Holden-Dye L; Neveu C
PLoS Pathog; 2018 May; 14(5):e1006996. PubMed ID: 29719008
[TBL] [Abstract][Full Text] [Related]
17. The anthelmintic pyrantel acts as a low efficacious agonist and an open-channel blocker of mammalian acetylcholine receptors.
Rayes D; De Rosa MJ; Spitzmaul G; Bouzat C
Neuropharmacology; 2001 Aug; 41(2):238-45. PubMed ID: 11489460
[TBL] [Abstract][Full Text] [Related]
18. Role of the outer beta-sheet in divalent cation modulation of alpha7 nicotinic receptors.
McLaughlin JT; Fu J; Sproul AD; Rosenberg RL
Mol Pharmacol; 2006 Jul; 70(1):16-22. PubMed ID: 16533908
[TBL] [Abstract][Full Text] [Related]
19. Effects of mutations of a glutamine residue in loop D of the alpha7 nicotinic acetylcholine receptor on agonist profiles for neonicotinoid insecticides and related ligands.
Shimomura M; Okuda H; Matsuda K; Komai K; Akamatsu M; Sattelle DB
Br J Pharmacol; 2002 Sep; 137(2):162-9. PubMed ID: 12208772
[TBL] [Abstract][Full Text] [Related]
20. Mutations of a conserved lysine residue in the N-terminal domain of alpha7 nicotinic receptors affect gating and binding of nicotinic agonists.
Criado M; Mulet J; Bernal JA; Gerber S; Sala S; Sala F
Mol Pharmacol; 2005 Dec; 68(6):1669-77. PubMed ID: 16129734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
